Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 10:40:47 UTC |
---|
Update Date | 2021-09-26 23:05:26 UTC |
---|
HMDB ID | HMDB0252698 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Gepirone |
---|
Description | Gepirone belongs to the class of organic compounds known as n-arylpiperazines. These are organic compounds containing a piperazine ring where the nitrogen ring atom carries an aryl group. However, similarly to buspirone, gepirone metabolizes into 1-(2-pyrimidinyl)piperazine, which is known to act as a potent antagonist of the α2-adrenergic receptor. Gepirone is a very strong basic compound (based on its pKa). However, in 2012 it once again failed to convince the FDA of its qualities for treating anxiety and depression. Gepirone is an antidepressant and anxiolytic drug of the azapirone group that was synthesized by Bristol-Myers Squibb in 1986 and has been under development for the treatment of depression but has yet to be marketed. In December 2015, the FDA once again gave gepirone a negative review for depression due to concerns of efficacy. However, in March 2016, the FDA reversed course and ruled favorably on the efficacy of gepirone. Gepirone was originally developed by Bristol-Myers Squibb, but was out-licensed to Fabre-Kramer in 1993. Unlike its relative buspirone however, gepirone has greater efficacy in activating the 5-HT1A and has negligible affinity for the D2 receptor (30- to 50-fold lower in comparison to buspirone). Moreover, the pro-sexual effects appear to be independent of its antidepressant and anxiolytic effects. This compound has been identified in human blood as reported by (PMID: 31557052 ). Gepirone is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Gepirone is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC1(C)CC(=O)N(CCCCN2CCN(CC2)C2=NC=CC=N2)C(=O)C1 InChI=1S/C19H29N5O2/c1-19(2)14-16(25)24(17(26)15-19)9-4-3-8-22-10-12-23(13-11-22)18-20-6-5-7-21-18/h5-7H,3-4,8-15H2,1-2H3 |
---|
Synonyms | Value | Source |
---|
Gepirone monohydrochloride | MeSH | 4,4-Dimethyl-1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-2,6-piperidinedione | MeSH | BMY-13805gepirone | ChEMBL | Ariza | ChEMBL | ORG-13011variza | ChEMBL |
|
---|
Chemical Formula | C19H29N5O2 |
---|
Average Molecular Weight | 359.474 |
---|
Monoisotopic Molecular Weight | 359.232125194 |
---|
IUPAC Name | 4,4-dimethyl-1-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}piperidine-2,6-dione |
---|
Traditional Name | gepirone |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC1(C)CC(=O)N(CCCCN2CCN(CC2)C2=NC=CC=N2)C(=O)C1 |
---|
InChI Identifier | InChI=1S/C19H29N5O2/c1-19(2)14-16(25)24(17(26)15-19)9-4-3-8-22-10-12-23(13-11-22)18-20-6-5-7-21-18/h5-7H,3-4,8-15H2,1-2H3 |
---|
InChI Key | QOIGKGMMAGJZNZ-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as n-arylpiperazines. These are organic compounds containing a piperazine ring where the nitrogen ring atom carries an aryl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazinanes |
---|
Sub Class | Piperazines |
---|
Direct Parent | N-arylpiperazines |
---|
Alternative Parents | |
---|
Substituents | - N-arylpiperazine
- Piperidinedione
- Dialkylarylamine
- Aminopyrimidine
- Delta-lactam
- Piperidinone
- N-alkylpiperazine
- Pyrimidine
- Piperidine
- Carboxylic acid imide, n-substituted
- Heteroaromatic compound
- Carboxylic acid imide
- Dicarboximide
- Amino acid or derivatives
- Tertiary aliphatic amine
- Tertiary amine
- Lactam
- Azacycle
- Carboxylic acid derivative
- Organic nitrogen compound
- Amine
- Organic oxygen compound
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Gepirone GC-MS (Non-derivatized) - 70eV, Positive | splash10-0m9r-2910000000-65e5547be23e1a515df1 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Gepirone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gepirone 10V, Positive-QTOF | splash10-03di-0119000000-de7074794efd4bed7c98 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gepirone 20V, Positive-QTOF | splash10-03di-1849000000-2fbcf6a293e322cce6ea | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gepirone 40V, Positive-QTOF | splash10-0a4l-6910000000-bfc19e3f25371e4a5cbd | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gepirone 10V, Negative-QTOF | splash10-0a4i-0309000000-becf30dc57a0817caa68 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gepirone 20V, Negative-QTOF | splash10-052f-0905000000-8b3c2cc81a46dd57ada9 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gepirone 40V, Negative-QTOF | splash10-0006-4910000000-4b1ae201d3a504fb083c | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gepirone 10V, Positive-QTOF | splash10-03di-0029000000-93ace071bda0a59752df | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gepirone 20V, Positive-QTOF | splash10-014i-0093000000-fd70a466fd2ca6d9fac7 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gepirone 40V, Positive-QTOF | splash10-00xr-1951000000-fb0dd0ddc57a7ac690eb | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gepirone 10V, Negative-QTOF | splash10-0a4i-0009000000-4cc5c8ea4f5e4a9dbb3b | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gepirone 20V, Negative-QTOF | splash10-0a4i-0019000000-a60c434ce652cfe0ddbe | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gepirone 40V, Negative-QTOF | splash10-090c-6921000000-af88b3e11a357b1edacc | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|